
Designer Drug Research Unit
@ddru_pubs
Highlighting research out of the Baumann lab aka the DDRU. The DDRU primarily studies the neuropharmacology of designer drugs & novel medications.
ID: 1347212724191834115
07-01-2021 16:05:47
9 Tweet
10 Followers
0 Following



Out now! Potential non-5-HT receptor targets of various #psychedelic tryptamines #Psilocybin-like effects and potency of 4-PrO-DMT in mice consistent with reports of its subjective effects 5-HT1A activity influenced 5-HT2A mediated HTR pubs.acs.org/doi/10.1021/ac… ACS Publications Bio & Med Chem Content


⏩️ Find the answers in this pre-proof on the comparative neuropharmacology of #U47700, #Ndesethylisotonitazene, #brorphine & more 🔀 In vitro + in vivo (rats) profiling ⏯️ doi.org/10.1016/j.drug… Always a pleasure to work with Dr Baumann and team! 🙌🌏 Designer Drug Research Unit Grant Glatfelter



Out now in @Psychopharm - Alkoxy chain length influenced the potency of #nitazene #opioids associated with human overdose. Christophe Stove Marthe Vandeputte Lei Shi link.springer.com/article/10.100…



The result of yet another fantastic collaboration with the Designer Drug Research Unit (Michael Baumann) group now out in @Psychopharm: 👇 Grant Glatfelter et al., "Alkoxy chain length governs the potency of 2-benzylbenzimidazole 'nitazene' opioids associated with human overdose." 👏 #nitazenes